comparemela.com

Page 8 - Eric Easom News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AN2 Therapeutics Nets $80 million for Novel Lung Disease Program

California-based AN2 Therapeutics secured $80 million in Series B funding round to help advance its novel nontuberculous mycobacterial lung disease program.

United statesStephanie wongPatricia martinEli lillyexecutiveEric easomCalithera biosciences incTherapeutics incSurveyor capitalAvidity partnersMonashee investment managementHatteras venture partnersLilly diabetesCalithera biosciencesN2 therapeutics nets 80 million for novel lung disease program

AN2 Therapeutics Closed $80 Million Series B Financing to Advance Novel Nontuberculous Mycobacterial Lung Disease Program

/PRNewswire/ AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious.

State of californiaUnited statesIndiana universityStephanie wongPatricia martinEric easomEli lillyKosan biosciencesUniversity of californiaAcelrx pharmaceuticalsHarvard business schoolTherapeutics incSciclone pharmaceuticalsBusiness administrationAlliance officerSurveyor capital

AN2 Therapeutics Closed $80 Million Series B Financing to Advance Novel Nontuberculous Mycobacterial Lung Disease Program

/PRNewswire/ AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious.

State of californiaUnited statesIndiana universityStephanie wongPatricia martinEric easomEli lillyKosan biosciencesUniversity of californiaAcelrx pharmaceuticalsHarvard business schoolTherapeutics incSciclone pharmaceuticalsBusiness administrationAlliance officerSurveyor capital

AN2 Therapeutics Closes $80M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

State of californiaUnited statesIndiana universityMenlo parkStephanie wongPatricia martinEric easomEli lillyKosan biosciencesUniversity of californiaAcelrx pharmaceuticalsHarvard business schoolTherapeutics incSciclone pharmaceuticalsBusiness administrationAlliance officer

AN2 Closes $80 Million Financing to Advance Nontuberculous Mycobacterial Lung Disease Program

AN2 Closes $80 Million Financing to Advance Nontuberculous Mycobacterial Lung Disease Program
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United statesStephanie wongPatricia martinCalithera biosciencesEric easomEli lillySurveyor capitalAvidity partnersMonashee investment managementHatteras venture partners

vimarsana © 2020. All Rights Reserved.